Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 156

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 8
Chunk 156
---
59  
     -  
     633,345  
     -  
     -  
     633,345 
  
    Opening
    Equity at February 14, 2024 (Successor) 
     10,089  
    $8,937,852  
     7,266  
    $1  
    $53,899,885  
    $(2,000,000) 
    $(63,185,641) 
    $(2,347,903)

NOTE
4 – NET LOSS PER SHARE OF COMMON STOCK

The
accounting standards require the presentation of both basic and diluted earnings per share on the face of the statements of operations.
The Company’s basic net loss per share is computed by dividing net loss attributable to common shareholders by the weighted average
number of shares of common stock outstanding for the period. If there are dilutive securities, diluted income per share is computed by
including common stock equivalents which includes shares issuable upon the exercise of stock options into shares of common stock, exercise
of preferred warrants into shares of preferred stock, and conversion of preferred stock into shares of common stock, net of any shares
assumed to have been purchased with the proceeds, using the treasury stock method. In periods for which the Company reports a net loss,
the common stock equivalents are not included, as they would be anti-dilutive.

13

The
following table summarizes the number of shares of Common Stock issuable upon conversion or exercise, as applicable, of convertible securities,
stock options, and warrants that were not included in the calculation of diluted net loss per share because such shares are anti-dilutive:

    For the 
    three and six 
    months ended 
    June 30,  
    For the
 three months ended June 30, 2024 and for the
    period from 
    February 14, 
    2024 
    through June 30,  
    For the 
    period from 
    January 1, 
    2024 
    through 
    February 14, 

    2025  
    2024  
    2024 

    (Successor)  
    (Successor)  
    (Predecessor) 
  
    Conversion
    of convertible preferred stock issued and outstanding 
     647,151  
     527  
     900 
  
    Conversion
    of convertible preferred